您的位置：首页 > 产品中心 > 33402-03-8， 间羟胺 (+)-酒石酸氢盐
间羟胺 (+)-酒石酸氢盐
Metaraminol (+)-bitartrate salt
产品别名
33402-03-8
间羟胺 (+)-酒石酸氢盐
Metaraminol (+)-bitartrate salt
(-)-m-Hydroxyphenylpropanolamine bitartrate salt
阿拉明 酒石酸氢盐
结构式
基本信息
| Empirical Formula【经验(实验)分子式】 | C9H13NO2 · C4H6O6 |
| Molecular weight | 317.29 |
| EC number【EC 号】 | 251-502-3 |
| MDL number | MFCD00238763 |
| PubChem Substance ID【PubChem化学物质编号】 | 24896944 |
| NACRES | NA.77 |
| Application【应用】 | Metaraminol (+)-bitartrate salt has been used to study the effects of adrenergic agonists in the mouse model of endometriosis. |
| Biochem/physiol Actions【生化/生理作用】 | α-adrenoceptor agonist. Metaraminol may serve as a false sympathetic transmitter. It is a mixed α - and β-adrenergic agonist. |
| Features and Benefits【特点和优势】 | This compound was developed by Merck & Co., Inc., Kenilworth, NJ, U.S.. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here. |
产品性质
| Quality Level【质量水平】 | 200 |
| originator【创始人】 | Merck & Co., Inc., Kenilworth, NJ, U.S. |
| SMILES string | O[C@H]([C@@H](O)C(O)=O)C(O)=O.C[C@H](N)[C@H](O)c1cccc(O)c1 |
| InChI | 1S/C9H13NO2.C4H6O6/c1-6(10)9(12)7-3-2-4-8(11)5-7;5-1(3(7)8)2(6)4(9)10/h2-6,9,11-12H,10H2,1H3;1-2,5-6H,(H,7,8)(H,9,10)/t6-,9-;1-,2-/m01/s1 |
| InChI key | VENXSELNXQXCNT-IJYXXVHRSA-N |
| packaging【包装】 | 1, 5 g in poly bottle |
安全信息
| Pictograms【象形图】 | GHS06 |
| Signal word【警示用语：】 | Danger |
| Hazard Statements | H301 + H311 + H331 |
| Precautionary Statements | P280 - P301 + P310 + P330 - P302 + P352 + P312 - P304 + P340 + P311 |
| Hazard Classifications【危险分类】 | Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral |
| Storage Class Code【储存分类代码】 | 6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects |
| WGK | WGK 3 |
| Personal Protective Equipment【个人防护装备】 | Eyeshields, Faceshields, Gloves, type P2 (EN 143) respirator cartridges |
